Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Othus, Megan  [Clear All Filters]
A
Allen, JD, Othus M, Shelton RC, Li Y, Norman N, Tom L, del Carmen MG.  2010.  Parental decision making about the HPV vaccine.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(9):2187-98. Abstract
B
Bhatia, S, Moon J, Margolin KA, Weber JS, Lao CD, Othus M, Aparicio AM, Ribas A, Sondak VK.  2012.  Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.. PloS one. 7(11):e48787. Abstract
C
Chen, TL, Estey EH, Othus M, Gardner KM, Markle LJ, Walter RB.  2013.  Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study.. Leukemia & lymphoma.
F
Fang, M, Storer BE, Estey EH, Othus M, Zhang L, Sandmaier BM, Appelbaum FR.  2011.  Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation.. Blood. 118(6):1490-4. Abstract
K
Karp, JE, Garrett-Mayer EL, Estey EH, Rudek MA, Smith DB, Greer JM, Drye MD, Mackey K, Dorcy KS, Gore SD et al..  2012.  Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.. Haematologica. Abstract
L
Lin, A, Othus M, McQuary A, Chi M, Estey E.  2012.  Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia.. Leukemia & lymphoma. Abstract
M
Margolin, KA, Moon J, Flaherty LE, Lao CD, Akerley WL, Othus M, Sosman JA, Kirkwood JM, Sondak VK.  2012.  Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (SWOG S0438).. Clinical cancer research : an official journal of the American Association for Cancer Research. 18(4):1129-1137. Abstract
Medeiros, BC, Othus M, Fang M, Roulston D, Appelbaum FR.  2010.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.. Blood. 116(13):2224-8. Abstract
Medeiros, BC, Othus M, Appelbaum FR.  2011.  Cytarabine dose for acute myeloid leukemia.. The New England journal of medicine. 364(22):2167-8;authorreply2168-9.
Medeiros, BC, Othus M, Estey EH, Fang M, Appelbaum FR.  2012.  Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia.. Haematologica. 97(9):1401-1404. Abstract
Medeiros, BC, Othus M, Fang M, Appelbaum FR, Estey EH.  2012.  Impact of residual normal metaphases in core binding factor acute myeloid leukemia.. Cancer. 118(9):2420-2423. Abstract
O
Ostronoff, F, Othus M, Ho PA, Kutny M, Geraghty DE, Petersdorf SH, Godwin JE, Willman CL, Radich JP, Appelbaum FR et al..  2012.  Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.
Othus, M, Moon J, Margolin K.  2011.  Melanoma's deadly march to the brain: by what route, and can it be stopped? Cancer. 117(8):1560-3.
Othus, M, Barlogie B, Leblanc ML, Crowley JJ.  2012.  Cure Models as a Useful Statistical Tool for Analyzing Survival.. Clinical cancer research : an official journal of the American Association for Cancer Research. 18(14):3731-3736. Abstract
Othus, M, Li Y.  2010.  A Gaussian Copula Model for Multivariate Survival Data. Statistics in Biosciences. 2(2):154-179.
Othus, M, Li Y, Tiwari R.  2012.  Change point-cure models with application to estimating the change-point effect of age of diagnosis among prostate cancer patients.. Journal of applied statistics. 39(4):901-911. Abstract
R
Roshal, M, Chien S, Othus M, Wood BL, Fang M, Appelbaum FR, Estey EH, Papayannopoulou T, Becker PS.  2012.  The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.
S
Shelton, RC, Snavely AC, De Jesus M, Othus M, Allen JD.  In Press.  HPV Vaccine Decision-Making and Acceptance: Does Religion Play a Role? Journal of religion and health. Abstract
W
Walter, RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, Appelbaum FR, Kantarjian HA, Estey EH.  2011.  Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(33):4417-24. Abstract
Walter, RB, Othus M, Burnett AK, Löwenberg B, Kantarjian HM, Ossenkoppele GJ, Hills RK, van Montfort KGM, Ravandi F, Evans A et al..  2013.  Significance of FAB subclassification of "Acute Myeloid Leukemia, NOS" in the 2008 WHO classification: analysis of 5,848 newly diagnosed patients.. Blood. Abstract
X
Xie, B, Othus M, Medeiros BC, Fang M, Appelbaum FR, Estey EH.  2011.  Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype.. Haematologica. 96(4):631-2.